Jonathan Young, Chief Operating Officer at Akero Therapeutics, Inc. (AKRO), sold 568 shares at $26.18 ($15K) on 2024-09-10, disclosed to the SEC on 2024-09-13.
Open-market sale of $15k AKRO by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AKRO | SELL | 2025-09-04 | $705K | — | Filing → |
| AKRO | SELL | 2025-08-13 | $1.2M | — | Filing → |
| AKRO | SELL | 2025-06-20 | $159K | — | Filing → |